Close this search box.

We are creating some awesome events for you. Kindly bear with us.

Virtual reality technology developed at UNSW allows multiple scientists to simultaneously ‘walk’ through cells

Virtual reality technology developed at UNSW allows multiple scientists to simultaneously ‘walk’ through cells

Researchers at the University of New South Wales (UNSW) have
a multi-user virtual reality (VR) technology that allows multiple
scientists to see inside a human cell at the same time. This is intended to
provide researchers a three-dimensional tool to improve doctor interaction and
help analyse how cancer drugs work.

UNSW Art & Design’s Associate Professor John McGhee is collaborating
with Professor Maria Kavallaris, from UNSW Medicine and Children’s Cancer
Institute on the project. They are investigators in the ARC Centre of
Excellence in Convergent Bio-Nano Science & Technology (CBNS). They are now
in the second phase of the Journey to the
Centre of the Cell project
, an initiative that combines scientific data,
microscopy images and animation to create a virtual reality (VR) world of cells
and blood vessels that can be seen through headsets.

The system takes data from scanning (such as serial
block-face scanning electron microscope imaging data) and visualises the dynamic
component over time. Rather than looking down a microscope at a two-dimensional
image, researchers can move around and be immersed in the data represented as a
three-dimensional image in virtual reality. 

Until now, individual researchers could go into their data with
single VR headsets. Now, multiple users from different parts of the world can ‘walk’
inside the landscape of the cell at the same time and annotate and interact with
their data simultaneously. The scientists can almost touch and feel the cell, travel
through it and around it and look at the structures within the cells. This
could allow scientists to be much more collaborative.

Kavallaris, a leading cancer biology researcher and
nanomedicine expert, says tracking 3D cells in tumours can show scientists what
happens when cells move in real time – information that can be used when
looking at the spread of cancer.

The movement of nano-particles can be tracked as they enter
the tumour. This enables highlighting of the area that can be targeted with
radiotherapy or chemotherapy. Ultimately this will assist in the development of
new types of cancer drugs and their accurate deployment.  

Above image: Screenshot from video accompanying press
release; video features animation by Associate Prof. John McGhee, Dr. Andrew Lilja
and John Bailey/ Credit: UNSW

Associate Prof. McGhee and CBNS Co-Chief Investigator
Professor Kavallaris are focussing on educating researchers on how cells
function and at the way drugs are internalised by cancer cells.

“We have never had access to something like this before. We
hope it will help scientists better understand how and what happens if you
interfere with a genetic process and add certain drugs. Eventually it could be
a tool to explain to patients and their parents about types of cancer and
strategies for treatment,” said Professor Kavallaris.

The technology is already being trialled on Monash
University pharmaceutical science students
 learning about cancer drug
delivery to see if it improves their understanding.

"We've now got data that shows by putting a
headset on and walking in virtual reality, we have seen a significant
improvement in their exam results, compared to others who were using
traditional media," Associate Prof. McGhee said.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


As a Titanium Black Partner of Dell Technologies, CTC Global Singapore boasts unparalleled access to resources.

Established in 1972, we bring 52 years of experience to the table, solidifying our position as a leading IT solutions provider in Singapore. With over 300 qualified IT professionals, we are dedicated to delivering integrated solutions that empower your organization in key areas such as Automation & AI, Cyber Security, App Modernization & Data Analytics, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Renowned for our consulting expertise and delivering expert IT solutions, CTC Global Singapore has become the preferred IT outsourcing partner for businesses across Singapore.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.